Slingshot members are tracking this event:

VX-152, VX-440 "triplet" potential Phase II efficacy data in hetero CF expected in early 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
VRTX Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 18, 2017
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Vx-152, Vx-440, Hetero Cystic Fibrosis